_Flightpath Biosciences operates an Australian subsidiary to conduct critical phase I human clinical studies in an efficient, high quality clinical environment.
As such, the company benefits from the generosity, altruism and scientific interest of volunteers, and contributions from experienced clinicians and talented scientists in the hopes of advancing safer, more effective therapies for patients. We are appreciative of the HRECs, the TGA and the Australian government's efforts in providing this opportunity to “move faster”.
Flightpath Biosciences Australia Pty Ltd is a wholly-owned subsidiary of Flightpath Biosciences, Inc.
